Skip to main content
Clinical Trials/TCTR20231021002
TCTR20231021002
Enrolling By Invitation
Phase 1

Calcium and Vitamin D supplementation with and without collagen on bone density and skin elasticity in menopausal woman-A randomized controlled study

niversity of Phayao and Maejo University0 sites80 target enrollmentOctober 21, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postmenopausal women
Sponsor
niversity of Phayao and Maejo University
Enrollment
80
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 21, 2023
End Date
October 30, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Phayao and Maejo University

Eligibility Criteria

Inclusion Criteria

  • 1\. Menopausal woman volunteers aged 45\-60 years
  • 2\. Good health, no swallowing problems. There were no serious illnesses or complications.
  • 3\. No history of receiving drugs in groups that suppress estrogen.
  • 4\. No history of regular consumption of alcoholic beverages or have used drugs
  • 5\. No history of smoking
  • 6\. Do not use anti\-inflammatory drugs or antibiotics or steroid drugs. or did not receive any medication within 14 days before administration of the research product and do not continue to use or give it throughout the duration of the research project.
  • 7\. No use or intake of dietary supplements, vitamins or minerals, herbs, and/or birth control pills within 14 days prior to administration of the study product, and do not continue to use or give it throughout the duration of the research project.
  • 8\. Do not inject fillers or stem cells, fat cells, or botulinum injections. Area to be tested.
  • 9\. Never participated in any other clinical studies. within 30 days before joining the study
  • 10\. No blood donation within 90 days before joining the study.

Exclusion Criteria

  • 1\. Have a history of illness or symptoms of allergies, diabetes, cardiovascular disease, liver disease, kidney disease, gastrointestinal disease, blood disease and/or other diseases. that may affect education

Outcomes

Primary Outcomes

Not specified

Similar Trials